TerminatedPhase 3NCT01622088
Phase 3 Extension Study of Dexpramipexole in ALS
Studying Amyotrophic lateral sclerosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Knopp Biosciences
- Principal Investigator
- Michael Bozik, MDKnopp Biosciences
- Intervention
- Dexpramipexole(drug)
- Enrollment
- 616 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2012 – 2013
Study locations (30)
- Barrow Neurological Institute - St. Joseph's Hospital, Phoenix, Arizona, United States
- University of California at San Francisco - Fresno, Fresno, California, United States
- University of California, Irvine, Orange, California, United States
- University of California, Davis, Sacramento, California, United States
- California Pacific Medical Center, San Francisco, California, United States
- Hospital for Special Care, New Britain, Connecticut, United States
- Mayo Clinic - Jacksonville, Jacksonville, Florida, United States
- University of Miami Miller School of Medicine, Miami, Florida, United States
- University of South Florida Medical Center, Tampa, Florida, United States
- Emory University, Atlanta, Georgia, United States
- Northwestern University, Chicago, Illinois, United States
- Indiana University, Indianapolis, Indiana, United States
- University of Iowa, Iowa City, Iowa, United States
- University of Kansas Medical Center, Kansas City, Kansas, United States
- Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
Biogen
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01622088 on ClinicalTrials.govOther trials for Amyotrophic lateral sclerosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07401186Stimulation-Based Modulation of Spinal and Cortical Sensory PathwaysPeter C. Gerszten, MD
- RECRUITINGNCT07467187Invasive Home Ventilation in DenmarkRigshospitalet, Denmark
- RECRUITINGNCT07259980A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)Biogen
- RECRUITINGNCT07502677Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral SclerosisRoyal Brompton & Harefield NHS Foundation Trust
- RECRUITINGNANCT07446114Functional Outcomes and Control Using Synchron BCI - CanadaSynchron, Inc.
- ENROLLING BY INVITATIONPHASE2, PHASE3NCT07410806HEALEY ALS Platform Trial - Regimen I NUZ-001Merit E. Cudkowicz, MD
- ENROLLING BY INVITATIONNANCT07298486Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALSNova Southeastern University
- ACTIVE NOT RECRUITINGPHASE1NCT07204977Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)National Institute of Neurological Disorders and Stroke (NINDS)